Mkt and Stem Cells Up on Job Report Friday 8.07

Friday 8.07.09: DOW +114(1.2%)@9,370..NAS +27(1.4%)@2,000..SP500 +13.4(1.3%)@1,010.48
BIO-Stem Index: 143.2 (+1.2% today, +43.2% ytd)
BIO-ETF Index: 109.92 (+.44% today, +9.9% ytd)
[Stem cell index beating biotech by 31%]

The market reacted to a jobs report that showed less job losses than expected by rising over 1% and re-establishing the recent uptrend. Stem cells also reacted, especially Opexa (OPXA, see our previous post for story link), up over 300% after inking a potential $50m deal with Novartis. The stock closed at .47 Thursday, opened at .82 Friday, and traded as high as 2.85 intraday on 30x normal volume, closing at 2.01 for a gain of 1.54 or 327% from the previous close.
Note: OPXA is too small to have been in our index; the market cap was 5.8m on Thursday, and is now just 24.6m. Had it been in the index, that would have seen a one day gain of around 14%!

Stem Cell Stocks (22 up, 10 down)
Big Winners: ASTM +7.1%, AVII +9.1%, CUR +6.1%, GHDX +6.6%, OPXA +327%
Losers: ATHS -3.8%, LMNX -11.5%, SQNM -17.4%

Swine Flu Stocks
AVII +9.1%, BCRX +5.1%, DVAX -1.65%, GILD +.7%, INHX +4.4%, INO -3.6%, NVAX -1%, SIGA -4.8%, SVA -1.1%

Other Biotech
Big Winners: ACAD +5.7%, ARQL +6.4%, CERS +5.3%, CLSN +6.8%, CPD +8.3%, DCTH +4.3%, ELRN +6.2%, MED +4.7%, NEOG +4.7%, ONXX +5%, SPPI +6.6%
Losers (5% ers): ALNY -4%, ANIK -6.7%, APT -4.3%, PLX -5.6%, SCLN -4.4%, SOMX -9.7%, XOMA -8.3%

Disclosure: long GERN, ONXX, FAS.